trending Market Intelligence /marketintelligence/en/news-insights/trending/SIyvkUe5gEmfrvdEabir6A2 content esgSubNav
In This List

Bellerophon director resigns, CEO joins board

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Bellerophon director resigns, CEO joins board

Bellerophon Therapeutics Inc. said in a Form 8-K filing that Matthew Holt resigned as a director Dec. 11.

Further, the Bellerophon board elected CEO Fabian Tenenbaum as a director.